Tag:
glaucoma
Latest Headlines
Latest Headlines
NicOx spikes on successful glaucoma drug study
Shares of France's NicOx spiked on the news that its experimental glaucoma drug licensed to Bausch & Lomb proved positive in a mid-stage study. According to their release two of the four...
Glaucoma-stricken rats see better, thanks to stem cells
Researchers at University College London have successfully used human eye stem cells to repair glaucoma damage in rats.
Altheos grabs $12.5M more, launches glaucoma trial
Drug developer Altheos has expanded its Series A round by an additional $12.5 million, just in time for the launch of a Phase IIa dosing trial for its glaucoma treatment. The South San Francisco
QLT's delivery plugs face issues, analyst says
Tear duct plugs to deliver eye drugs face some challenges, such as keeping the tiny devices in place to release treatments. QLT ( $QLTI ), the Canadian eye drug specialist, has been on pushing ahead
QLT reports success with eye drug delivery, analyst skeptical
Vancouver-based QLT ( $QLTI ), a developer of plugs inserted at the opening of the tear ducts to deliver eye treatments, is reporting that its Latanoporst punctal plug delivery system is certainly
Newly discovered genes could lead to earlier glaucoma diagnosis
Open angle glaucoma is the most common form of glaucoma, yet it is still poorly understood and difficult to diagnose early. And by the time the vision loss is detected, it is too late to do anything
Researchers set sights on glaucoma vision loss
With Baby Boomers not getting any younger (last we checked) glaucoma is likely to be one of many age-related diseases receiving increased scrutiny. A new study published in the Proceedings of the
New drug class could have wide health impact
Vaptans are a new class of drug that target a wide variety of conditions by inhibiting vasopressin, which regulates the circulatory system. Among the new drugs in development are relcovaptan, which
NicOx shares plunge on Pfizer trial failure
Shares of France's NicOx tumbled 38 percent after Pfizer announced that it would not advance their
deCODE discovers key to a subset of glaucoma
Scientists at Iceland's deCODE Genetics have found the genetic mutation that causes exfoliation glaucoma, a primary cause of blindness in the elderly. A mutation in the LOXL1 gene is apparently the
